Are drops or premium IOLs the long-term solution for presbyopia?

Click here to read the Cover Story, "Presbyopia-correcting drops broaden options for younger patients."

The future for presbyopia is bright no matter what side you are on. For drops, the benefits are that they are nonsurgical and well tolerated, and the risk profile is relatively safe. The con is that for many patients, they will not work.
Drops work well in early-stage presbyopia, but we know anecdotally that they do not work as well in older patients or those with later-stage presbyopia. There is also a possibility for some adverse effects such as headaches and eye redness, although the risk